Thus, this is suggestive that forced depletion of PTPRK contributes to the aggressive properties of CD133‐positive colon cancer cells through the potentiation of the pro‐oncogenic CD133–AKT pathway (Fig. 6). The gene discussed is PTPRK; the disease is colonic neoplasm.